Advisory panel recommended removal of Makena from market by a vote of 9-7 and the 7 who recommended it stay on the market want a new confirmatory study. Not shocking news and also not great news for AMAG, it's now in the hands of the FDA.
Remember this chestnut? https://medium.com/@midwifeamy/why-arent-we-more-skeptical-of-progesterone-for-preventing-preterm-birth-cb68ab681f14
Earnings call on Friday is going to be interesting, I'd make popcorn but it's a bit early for that, maybe waffles.
If the miserable earnings report on Friday doesn’t get Heiden and his band of marketing idiots fired then who will pay for this cluster? Oh that’s right- the sales team of course.
I heard there is an important announcement regarding percent DAW for Makena on this Friday’s earnings report!!
Julie Kropp the Valley Goth revisited. No progress on clinical trials. None! Failed miserably at the FDA Ad Com. Celebrated as a HERO for failure. Was worried about picking out her 8 inch heals that day instead of finding some Science! The entire company hates her and hates her miserable misfits. These folks that can work from home every day and still expect a clinical trial to get done. She wanted to do a Prolong trial in Europe so her folks could get some first class airline tickets. She will sink the company and Heiden. To bad CALIGAN does not know the real cause of the failure.
Yes, what exactly has she done for us? Why do the cuts always need to come from sales? When is the company going to progressively cut where the least amount of return is being achieved? We lost a lot of good people in February that did not deserve to be cut. What is wrong with this company? Where are your brains besides up your ass?
Here is another article: https://www.fiercepharma.com/pharma/fda-committee-recommends-pulling-premature-birth-med-makena-from-u-s-market
Well said...company is more concerned with keeping their friends employed than the people that are doing the work. Oh and good luck if you disagree with them...you will be marked for as long as your stay is here.